Clinical Trial Update: Abatacept for the Treatment of Giant Cell Arteritis [Phase 3]

View source ↗

Summary

Ongoing Phase 3 clinical trial evaluating abatacept for giant cell arteritis; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Arteritis

Drugs mentioned

• Abatacept (abatacept)

Snippet

Sponsor: University of Pennsylvania | Conditions: Giant Cell Arteritis | Phase 3 | Status: RECRUITING